HEALTHSTAT NEWS
STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more
A bill introduced by Sen. Bill Cassidy (R-La.) aims to overhaul the 340B drug discount program by implementing restrictions such as retroactive rebates and sliding-fee scales for hospitals. Jeff Vacirca, a physician and leader of a New York oncology group, is among candidates being considered for FDA commissioner by the Trump administration.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Cassidy proposes bill to rein in 340B drug discount program
- STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program
- STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
- STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says